Regeneron Stock Rose on COVID-19 Breakthrough
In this episode of Market Foolery, Mac Greer and Motley Fool analyst Jason Moser cover some of the day's headlines. They assess market sentiment. The Fed steps in to stimulate businesses. Learn how to approach markets in trying times. Regeneron Pharmaceuticals (NASDAQ: REGN) announces a breakthrough in the fight against COVID-19, and much more.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Source Fool.com
